We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Team Successfully Tag Telomerase To Track Its Activity in Tumor Cells

Team Successfully Tag Telomerase To Track Its Activity in Tumor Cells

Team Successfully Tag Telomerase To Track Its Activity in Tumor Cells

Team Successfully Tag Telomerase To Track Its Activity in Tumor Cells

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Team Successfully Tag Telomerase To Track Its Activity in Tumor Cells"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Canadian scientists have achieved a first in the study of telomerase, an essential enzyme implicated in aging and cancer.

In today’s edition of the prestigious journal Molecular Cell, scientists from Université de Montréal used advanced microscopy techniques to see single molecules of telomerase in living cells.

A flaw in the replication of chromosomes means that they get shorter  with each cell division. If nothing is done to correct this error, replication stops and cells go into a state called senescence, a hallmark of aging. Normally, telomerase adds extra DNA to the ends of chromosomes to prevent this problem, but as we age our bodies produce fewer of them.

Cancer cells, on the other hand, become immortal by switching telomerase back on, allowing cells to divide indefinitely. This re-activation is among the first steps that direct cells to become cancerous, but the process remains poorly understood. If researchers knew more about it, they could offer hope for some form of therapy to combat it.

Now an Université de Montréal team led by biochemistry professor Pascal Chartrand, in collaboration with cell biologist Agnel Sfeir at the Skirball Institute in New York, has succeeded in tagging telomerase with several ultrabright fluorescent molecules – something that’s never been done before.

“With this technological breakthrough, we observed that telomerase continuously probes telomeres, but becomes engaged at the ends of chromosomes following a two-step binding mode,” said UdeM biochemist Hadrien Laprade, who, with his colleague Emmanuelle Querido,  conducted the experimental investigations.

In their study, the scientists also show how mutation of a telomeric regulatory factor results in an unrestrained access of telomerase to the tips of telomeres, an event that promotes tumorigenesis.

“This new technology now provides sufficient details of how a key actor in cancer works at the molecular level, the first step in developing novels therapeutic strategies to thwart its activity,” said Chartrand.

“It could take years before we get there, but this is an important first step.”

Reference: Laprade, et al. (2020) Single-Molecule Imaging of Telomerase RNA Reveals a Recruitment-Retention Model for Telomere Elongation. Molecular Cell DOI: https://doi.org/10.1016/j.molcel.2020.05.005

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.